KURA
KURA
NASDAQ · Biotechnology

Kura Oncology Inc

$8.26
-0.17 (-2.02%)
As of Mar 22, 10:17 PM ET ·
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Buy 18 86%
Hold 3 14%
Sell 0 0%
Price Target
Analyst Price Target +455.9% upside
Low Target $25.11
Average Target $45.92
High Target $52.51
Current Price $8.26
Current
$8.26
Target
$45.92
$25.11 $45.92 avg $52.51
Scenario Analysis
Bear Case
$25.11
204.0%
Low target
Base Case
$45.92
+455.9%
Avg target
Bull Case
$52.51
+535.7%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$12.49
-33.9% from high
52-Week Low
$5.41
+52.7% from low
Target vs 52W High
$45.92
+267.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%